List view / Grid view

Steve Bremer (European Pharmaceutical Review)

 

Improving patient access, the UCB way

23 November 2017 | By

UCB’s ambition, according to its website, is to transform the lives of people living with severe diseases. The company’s Head of Global Clinical Development and Medical Affairs Stuart Dollow believes that making its clinical trial design more patient-centred and creating the right partnerships are key steps toward improving access to…

Send this to a friend